Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience

Simultaneous bilateral mastectomy and RRSO for BRCA2-positive non-invasive breast cancer in Japan: a case report and analysis of initial experience

Abstract Background In Japan, genetic testing, surveillance, and risk-reducing surgery for hereditary breast and ovarian cancer (HBOC) syndrome have been covered by the Japanese national insurance system since April 2020. On the other hand, the current situation is that medical care, including surve...

Full description

Bibliographic Details
Main Authors: Aya Tanaka, Megumi Matsumoto, Mami Takao, Shoko Miura, Yuri Hasegawa, Ryota Otsubo, Hiroko Hayashi, Ichiro Isomoto, Kiyonori Miura, Takeshi Nagayasu
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Hereditary Cancer in Clinical Practice
Subjects:
Hereditary breast and Ovarian cancer
BRCA1
BRCA2
Contralateral risk-reducing mastectomy
Risk-reducing salpingo-oophorectomy
Online Access:https://doi.org/10.1186/s13053-023-00268-y

Internet

https://doi.org/10.1186/s13053-023-00268-y

Similar Items